Cibus to Participate in Alliance Global Partner’s Annual Virtual Healthcare Company Showcase
Cibus (NASDAQ: CBUS), an agricultural biotechnology company specializing in proprietary gene editing technologies for seed trait development, announced its participation in the AGP Annual Virtual Healthcare Company Showcase.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Cibus (NASDAQ: CBUS), an agricultural biotechnology company specializing in proprietary gene editing technologies for seed trait development, announced its participation in the AGP Annual Virtual Healthcare Company Showcase. Peter Beetham, Co-Founder, President, and Interim CEO, will present on May 21, 2025, at 4:40 p.m. ET.
The presentation will cover three main areas: the company's progress in advancing its gene-editing technology platform, recent regulatory developments supporting agricultural innovation, and Cibus' commercialization strategy for its productivity trait pipeline.
Details
News Market Reaction – CBUS
The recorded move for CBUS in the trading session of this news was -9.46%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will host a presentation at the AGP Annual Virtual Healthcare Company Showcase.
During the presentation, Dr. Beetham will discuss the Company's progress in advancing its gene-editing technology platform, recent regulatory developments supporting agricultural innovation, and Cibus' commercialization strategy for its productivity trait pipeline.
Presentation Details
Date: Wednesday, May 21, 2025
Time: 4:40 p.m. ET (1:40 p.m. PT)
Webcast link: https://us02web.zoom.us/webinar/register/WN_jB1HgKLvQFmUfC6VBT11mw
About Cibus
Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately
CIBUS CONTACTS:
INVESTOR RELATIONS
Karen Troeber
ktroeber@cibus.com
858-450-2636
Jeff Sonnek – ICR
jeff.sonnek@icrinc.com
MEDIA RELATIONS
Colin Sanford
colin@bioscribe.com
203-918-4347
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.